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Abstract Several studies have demonstrated the rabies
virus to be a perfect potential vaccine vector to insert
foreign genes into the target genome. For this study, a
green fluorescent protein (GFP) gene was cloned into the
rabies virus (RABV) genome between the N and P gene.
CT dinucleotide was inserted as intergenic region. The
recombinant high egg passage Flury strain (HEP-Flury) of
RABV, carrying GFP (rHEP-NP-GFP), was generated in
BHK-21 cells using reverse genetics. According to the viral
growth kinetics assay, the addition of GFP between N and
P gene has little effect on the viral growth compared to the
parental strain HEP-Flury. Quantitative real-time PCR
(qPCR) indicated that rHEP-NP-GFP showed different
viral gene transcription, especially for G gene, compared to
HEP-Flury. The same is true for one other recombinant
RABV carrying GFP between G and L gene in NA cells. In
addition, parent HEP-Flury showed more expression of
innate immune-related molecules in NA cells. Compared to
HEP-Flury, Western blotting (WB) indicated that insertion
of a foreign gene following N gene enhanced the expres-
sion of M and G proteins. According to the qPCR and WB,
GFP expression levels of rHEP-NP-GFP were significantly
higher than rHEP-GFP. This study indicates HEP-Flury as
valid vector to express exogenous genes between N and P.
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Introduction
Rabies virus (RABV) causes a fatal neurological disease
both in humans and animals and more than 55,000 humans
die of rabies each year with most cases occurring in
developing countries [1–3]. RABV, an unsegmented, neg-
ative-stranded RNA virus, belongs to the genus Lyssavirus
of the family Rhabdoviridae. The RABV genome is
approximately 12 kb in size and comprises five genes that
are encoding nucleoprotein (N), phosphoprotein (P),
matrixprotein (M), glycoprotein (G) and the RNA-depen-
dent RNA polymerase (L) [4]. Ribonucleoprotein, formed
by RNA and N, together with P and L forms the viral
replication complex [5]. RABV G and M regulate the RNA
synthesis and affect the RV pathogenesis by regulating
virus replication and by facilitating cell-to-cell spread [6,
7]. M bridges the RNP and the cytoplasmic domain of G to
form the bullet-shaped virion [8]. A leader sequence at the
30 end and a trailer sequence at the 50 end of the RABV
genome are conservative. From the 30 end, a gradient of
transcription occurs that follows the gene order 30-lerder-
N-P-M-G-L-trailer-50. This gradient results in the most
abundant viral transcripts of N mRNAs and the least
abundant transcripts of L mRNAs in infected cells [9, 10].
Sequences were not transcribed in the intergenic region
(IGR), which in turn affects the transcription of the virus
gene [11]. Different IGRs, including the amount and type
of nucleotide, resulted in a transcription change of down-
stream and upstream genes in VSV [12]. The five genes of
RABV are separated by four IGRs comprising different
numbers of nucleotides (2nt, 5nt, 5nt, and 423nt). CT
dinucleotide of RABV N/P profoundly improved the
transcription of downstream genes without affecting the
upstream gene compared to other intergenic regions (P/M,
M/G, and G/L). For this study, CT dinucleotide was chosen
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as the intergenic region between N and the exogenous
gene.
High flexibility and straightforward manipulation make
RABV a desired vector. Both foreign proteins and addi-
tional glycoprotein have been expressed by recombinant
RABVs that carry exogenous genes between the G and L
genes [13–18]. Most of the studies indicated that viral
growth was not affected by the insertion of exogenous
genes between G and L while [17, 19]. Some either posi-
tively or negatively influenced the viral growth in vitro,
which may be related to the specifications of foreign pro-
tein [17, 19]. The SRV9 strain of RABV was used as a
vector for expression of exogenous genes between P and
M, which lead to no influence on virus packaging and
growth characteristics [20]. In addition, human immunod-
eficiency virus type 1 Gag (HIV-1 Gag) was expressed in
RABV between N and P and showed no differences in
virus titers compared to parent RABV. However, Western
blotting revealed that the expression of HIV-1 Gag
between N and P was not enhanced in comparison to the
expression between G and L, although it was located fur-
ther upstream [21].
The labeling protein green fluorescent protein (GFP) is
directly visible in fluorescent microscopy. Recombinant
RABV expressing GFP between G and L has been used for
research on RV mechanisms and to test virus-neutralizing
antibodies [22, 23]. In addition, the expression of foreign
proteins generally affects the characteristics of recombi-
nant RABV including pathogenicity, growth, immuno-
genicity, and expression of structural proteins. For this
study, a GFP gene carrying the transcription initiation
signal and the transcription termination polyadenylation
signal was first cloned into the HEP-Flury genome at the
site between N and P genes. The intergenic region of the
CT dinucleotide was introduced between N and GFP. The
expression levels of viral genes and GFP were explored in
NA cells infected by recombinant RABVs or parent HEP-
Flury. The data indicates that foreign protein can be
expressed in abundance through genes inserted between N
and P. Through this technique, the growth of RABV is not
affected.
Materials and methods
Cells, viruses, and antibodies
Baby hamster kidney (BHK-21) cells were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) (Gibco,
Invitrogen, China) and contained 10 % fetal bovine serum
(FBS) (Gibco, Australia). Mouse neuroblastoma (NA) cells
were cultured in RPMI 1640 medium (Gibco, Invitrogen,
China) supplemented with 10 % FBS. HEP-Flury and
rHEP-GFP were propagated in BHK-21 cells. rHEP-GFP, a
recombinant virus that carries GFP between the G and L
genes, was previously rescued from the constructed plas-
mid [24]. Antibodies against both the RABV N, RABV M,
and RABV G proteins that were used for Western blotting
were stored in our laboratory. Fluorescein isothiocyanate
(FITC)-conjugate antibodies against the RABV N protein
were purchased from Fujirabio Inc. (Malvern, PA). Anti-
bodies against GFP were purchased from Beijing Emarbio
Science & Technology Co., Ltd.
Construction of full-length cDNA clones
The recombinant RABV infectious clones were constructed
by inserting the GFP gene between N and P genes. The
fragment of GFP cDNA including transcription initiation
signal (TIS) and transcription termination polyadenylation
signal (TTP) was amplified by PCR using the primers:
cGFP-forward (50-ATCATGAAAAAAACTAACACCTCT
CGTACGATGGCTAGCAAAGG-30, homologous sequence
underlined) and cGFP-reverse (50-CGAAAGGAGGAGT
Fig. 1 The linear vector was
amplified using primers on the
N and P genes with the template
of plasmid pHEP-3.0 by PCR.
GFP fragments were amplified
carrying homolog’s sequences
and reacted with the linear
vector according to the
manufacturer’s instructions
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GTTAGTTTTTTTCTCGACTGAAATGCT-30, homologous
sequence underlined). The linear vector was amplified from
the rabies virus full-length cDNA vector (pHEP-3.0) using the
primers: Li-NP-forward (50-CTAACACTCCTCCTTTCGAA
CCATCCCAAGTATGAGCA-30, homologous sequence
underlined) and Li-NP-reverse (50-AGTTTTTTTCATGAT
GGATATACACAATC-30, homologous sequence under-
lined). The linear vector was used for the construction of
recombinant RV cDNA clones. The GFP fragment was
cloned into the corresponding site of the linear vector by a
recombinant reaction using the ClonExpressMultiS One Step
Cloning Kit (Vazyme Biotech CO., Ltd., Nanjing), following
to the manufacture’s instructions. The route of cloning is
shown in Fig. 1. Restriction analysis and DNA sequencing
(Genwiz, Shuzhou) were used to identify the resulting plas-
mid (prHEP-NP-GFP).
Rescue of recombinant virus from cDNA
Recombinant rabies virus was rescued as previously
described [21]. Briefly, BHK-21 cells grown in 12-well
plates (Corning, USA) were transfected with 1.0 lg of
pHEP-NP-GFP plasmid, 0.25 lg of pH-N, 0.125 lg of pH-
P, 0.05 lg of pH-L, and 0.075 lg of pH-G, respectively.
The SuperFect transfection reagent (Qiagen, GER) was
used according to the manufacturer’s protocol. After
incubation at 37 C for 4 days, the culture medium was
removed and fresh medium was added to the cells. Incu-
bation at 37 C was kept until the green fluorescent spots
became visible in fluorescence microscopy (after
*4 days). By this point, the cell culture medium was
collected and viruses were detected using FITC-conjugated
antibodies against the RABV N protein. Briefly, the cell
culture medium was then discarded, and the cells were
fixed with 80 % pre-cold acetone for 30 min at -20 C.
The cells were then washed three times with PBS and
stained with FITC-conjugated anti-RABV N antibody at
37 C. Foci were tested under a fluorescence microscope
(AMG, USA). To confirm whether the rescued rRABV was
derived from the cloned pHEP-NP-GFP, RT-PCR was
performed using the primers: N-forward (50-TGACAGG
GTGCCAGAAAT-30) and P-reverse (50-TAGGAAAGTT
GACCGAGA-30).
Virus titration
rRABVs (rHEP-GFP and rHEP-NP-GFP) were propagated
in BHK-21 cells. For virus titration, monolayers of BHK-
21 cells were infected in 96-well plates, using serial
10-fold dilutions of virus and incubated at 37 C. 96-h
post-infection, foci of GFP were counted under a fluores-
cence microscope and calculated as focus forming units/ml
(FFU/ml).
Virus multi-step growth assays
For the multi-step growth curve, monolayers of NA or
BHK-21 cells were cultured in 9-cm cell culture dishes and
were infected with various viruses at a multiplicity of
infection (MOI) of 0.01 FFU. After 1 h of incubation at
37 C, the inoculum was discarded and the cells were
washed three times with phosphate-buffered saline (PBS).
8 mL fresh growth medium was added into cells followed
by further incubation at 37 C. Samples of culture super-
natant were collected at 24, 48, 72, 96, and 120 h after
infection. Virus titer was determined in BHK-21 cells as
previously described.
Quantitative real-time PCR
To investigate the expression of N, P, M, G, L, and GFP
genes as well as that of innate immune-related molecules,
Table 1 Primers used for the analysis of genes expression [17]
Gene Left primer (50-30) Right primer (50-30)
RABV N TTTAGTCGGTCTTCTCCTGAGTCT AATCTGCTCTATTCTATCCGCAATGT
RABV P GAGTCCAAATAGTCAGACAAATGAGGT AGGAAAGTTGACCGAGACATAGGA
RABV M AGAGGACAAAGACTCTTCTCTGCT TGGAGTTAAGCCCGTATGTTCTCT
RABV G GCCTTGATTGCCCTGATGTTGATAA CATTTCTCCCTGTCCCTCCAAGAT
RABV L TGTTGATGTCTGATTTCGCATTGTCT AAGGGAACGCTCTTGACAGATGT




IFN a1 GAGAAGAAACACAGCCCCTG TCAGTCTTCCCAGCACATTG
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BHK-21 cells were infected with various viruses at an MOI
of 0.1. This was done in 6-well cell culture plate and
incubation at 37 C followed the infection. Cells were
harvested and total RNA was extracted using the Total
RNA Kit II (OMEGA, USA) according to the manufac-
turer’s protocol. Reverse transcription (RT) was carried out
using the Transcriptor First Strand cDNA Synthesis Kit
(Roche, GER) according to the manufacturer’s instructions.
Each reaction was carried out in triplicate using SYBR
Green Master Mix (Vazyme Biotech CO., ltd., Nanjing)
and following the manufacturer’s instructions. Quantitative
real-time PCR (qPCR) was carried out in a CFX384 Real-
Time System (Bio-Rad, USA). To analyze the expression
of target genes and virus genome, Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as reference
gene. The primers used to amplify target and reference
genes are shown in Table 1.
Western blot
NA cells cultured in 6-well plates were infected with dif-
ferent viruses at an MOI of 0.1. After incubation at 37 C
for 24 and 72 h, protein samples were harvested to inves-
tigate the expression of proteins RAV N, RABV M, RABV
G, and GFP in vitro. Briefly, NA cells were washed three
times with PBS after the discarding of culture medium and
then lysed on ice using RIPA buffer (Beyotian, China). The
lysates were centrifuged at 13,000 rpm for 20 min and all
supernatants were collected. Proteins were separated by
SDS-PAGE, and subsequently transferred on to PVDF
membranes and incubated with antibodies against RABV
N, RABV M, RABV G, GFP, or b-actin. After a second
incubation with goat anti-mouse antibody labeled with
horseradish peroxidase (HRP), the membranes were
stained with BeyoECL Plus A and B (Beyotime, China)
according to the manufacturer’s instructions. Protein fin-
gerprints were shown using Fine-do 96 (Tanon, China).
Results
Generation of recombinant RABV expressing GFP
between N and P genes
Previous studies have shown that intergenic regions play an
important role in gene expression [25]. The GFP gene with
a TIS and a TTP was cloned into the pHEP-3.0 genome
(see Fig. 2a). For this study, CT dinucleotide was inserted
as intergenic region between N and GFP, as well as
between GFP and P. Sequencing the fragments within the
infectious clones confirmed whether the insertion of the
GFP was successful. The recombinant RABV was col-
lected from BHK-21 cells using previously described
procedures [26], resulting in rHEP-NP-GFP. A second
recombinant RABV carrying the GFP gene between G and
L was previously rescued by Liu Xiaohui et al. [24] and
Fig. 2 Generation of
recombinant RABV expressing
GFP between N and P genes.
a The recombinant RABV
(rRABV) expressing GFP
between N and P was
constructed based on the HEP-
Flury (see Sect. 2.2). The
rRABV contains an additional
transcription initiation/
termination polyadenylation
signal and CT dinucleotide
intergenic region between the N
and P genes using seamless
cloning. b Test of expression of
rHEP-NP-GFP. BHK-21 cells
were infected with rRABV at an
MOI of 0.1. GFP expression
was identified at 48 h post-
infection directly under a
fluorescence microscope
without antibody. c rRABV was
confirmed. FITC-conjugated
anti-RABV N antibody was
used for the test of rRABV on
BHK-21 cells post-infection
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was named rHEP-GFP. This GFP had the same TIS and
TTP as rHEP-NP-GFP. The GFP expression of rHEP-NP-
GFP was directly measured (Fig. 2b) using BHK-21 cells
at 48 h post-infection by means of fluorescence micro-
scopy. To determine the rescued rRABV content, direct
fluorescent antibody assay (dFA) was conducted with
FITC-conjugated anti-RABV N antibody on BHK-21 cells
(Fig. 2c).
Virus multi-step growth assays
To determine the growth characterization of rHEP-NP-
GFP, viral kinetics were examined in both BHK-21 cells
and NA cells. As shown in Fig. 3, no difference between
the values was detected except for rHEP-NP-GFP reaching
the highest titer at day 5. This study indicates that the late
rHEP-NP-GFP titers were affected by the insertion of the
exogenous gene in both BHK-21 cells and NA cells.
Recombinant rHEP-NP-GFP showed a slower virus pro-
duction, which may be related to the changes in the ratio of
RABV proteins.
Quantitative RT-PCR analysis of viral transcription
and induction of innate immune-related molecules
in vitro
In order to investigate the effect of both viral transcription as
well as induction of innate immune-related molecules (caused
by insertion of exogenous gene in vitro), NA cells were
infected with HEP-Flury, rHEP-GFP, or rHEP-NP-GFP,
respectively; at an MOI of 0.1 and at 1 dpi or 3 dpi, cells were
harvested to determine the expression of viral genes (N, P, M,
G, L, and genomic RNA), GFP, and innate immune-related
molecules (ISG20, IFNa1, and STAT1).Quantitative real-time
PCRwas used for this as described previously [17]. As Fig. 4a
shows, the expressions of all viral genes of HEP-Flury were
less than those of rHEP-NP-GFP at 1 dpi while it increased at 3
dpi. Viral genome of HEP-Flury was expressed at a lower level
at 3 dpi compared to rHEP-NP-GFP. Throughout all levels,
rHEP-GFP showed irregular transcription compared to HEP-
Flury and rHEP-NP-GFP. In addition, rHEP-NP-GFP showed
a much higher level of G expression than HEP-Flury and
rHEP-GFP at 1 dpi, although its G gene was distant from
promoter. This may be due to the insertion of the CT dinu-
cleotide intergenic region betweenN andGFP [12], whichmay
indirectly affect the transcription of RABV G. Details about
mRNA expression of innate immune-related molecules are
shown in Fig. 4b. HEP-Flury showed a higher expression
inducing the ability of ISG20, IFNa1, and STAT1 than rHEP-
GFP and rHEP-NP-GFP at 1 dpi. At 3 dpi, NA cells infected by
rHEP-NP-GFP expressed more ISG20 and IFNa1 than rHEP-
GFP and HEP-Flury. The difference of GFP expression
between rHEP-GFP and rHEP-NP-GFP is shown in Fig. 4c. At
1 dpi, GFP was profoundly more expressed (about 3 fold) in
NA cells infected by rHEP-NP-GFP compared to rHEP-GFP.
Western blot analysis of GFP, N, M, and G proteins
expression in NA cells
Expression ofGFP,N,M, andGproteinswas analyzed inNA
cells infected with HEP-Flury, rHEP-GFP, and rHEP-NP-
GFP.Western blotting was used for this analysis, with target
protein expression relative to b-actin (Ratio of GFP/b-actin,
N protein/b-actin, M protein/b-actin, and G protein/b-actin).
Figure 5 shows the time-dependent GFP expression rates
with significantly higher rates for rHEP-NP-GFP compared
to rHEP-GFP for day 1. RABVs (HEP-Flury, rHEP-GFP,
and rHEP-NP-GFP) showed a different ability in expression
of N, M, and G protein. On day 1, N, M, and G proteins
showed lower expression rates in HEP-Flury-infected NA
cells compared to rRABVs. A comparison of expression
rates of N andMproteins between rHEP-GFP and rHEP-NP-
GFP showed no significant differences. The exception was
M protein of rHEP-GFP, which is expressed at a higher level
compared to that of rHEP-NP-GFP (at 1 dpi). The G protein
Fig. 3 Growth curves of rRABVs (rHEP-GFP and rHEP-NP-GFP)
and parental virus (HEP-Flury) in BHK-21 (a) and NA (b) cells.
BHK-21 cells or NA cells were infected with HEP-Flury, rHEP-GFP,
or rHEP-NP-GFP, respectively, at a multiplicity of infection (MOI) of
0.01. At days 1, 2, 3, 4, and 5 after infection, culture supernatants
were harvested and virus titers were determined
Virus Genes (2016) 52:379–387 383
123
expression of rHEP-NP-GFP was profoundly higher com-
pared to HEP-Flury and rHEP-GFP at 1 dpi.
Discussion
The intergenic region (IGR), which could not be tran-
scribed, plays an important role in affecting downstream
RNA transcription [12]. Recent research indicates
regulation of L gene expression of RABV by the intergenic
regions between G and L [25]. Five genes of RABV are
separated by four IGRs comprising different numbers of
nucleotides, 30-50 namely, 2, 5, 5, and 423 nucleotides. In
this study, intergenic nucleotides (CT) were cloned into N
and GFP in order to enhance GFP expression as well as
other downstream genes.
Previous studies propose RABV to be a promising viral
vector to express exogenous genes [27]. GFP, as a reporter
Fig. 4 (a, b, c) Expression of viral genes, GFP, and innate immune-
related molecules in vitro. NA cells were infected with HEP-Flury,
rHEP-GFP, or rHEP-NP-GFP at an MOI of 0.1, and at 1 day post-
infection (dpi) or 3 dpi. Cells were harvested for measuring the
expression of viral genes (N, P, M, G, L, and genomic RNA), GFP,
and innate immune-related molecules (ISG20, MusIFNa1, and
STAT1) by means of quantitative real-time PCR. All expression of
target genes was normalized to the expression level of the reference
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by means
of calculation of 2-44CT. Data were analyzed using Bio-Rad CFX
Manager and GraphPad Prism 5. Asterisks indicate significant
differences of rHEP-GFP and rHEP-GFP compared to HEP-Flury
(a) and differences among the experimental groups (b, c), as
calculated by one-way ANOVA (*p\ 0.05; **p\ 0.01;
***p\ 0.001)
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gene, has been introduced into RABV between P and M or
G and L [20, 22–24]. For this study, GFP was cloned into a
HEP-Flury strain of RABV between N and P. Real-time
PCR and Western blot were conducted to investigate the
expression rates of rHEP-NP-GFP GFP in NA cells. As
shown in Figs. 4 and 5, expressions of both GFP mRNA
and protein of rHEP-NP-GFP were significantly higher
compared to rHEP-GFP. This may be due to the location of
GFP between N and P which is closer to the promoter
region [28]. Other studies indicate that in VSV and RABV,
both amount and type of nucleotides of intergenic
sequences affect the transcription of downstream as well as
upstream genes [12, 25]. CT dinucleotide as intergenic
region increases the transcription of downstream genes.
In previous studies, the glycoprotein (G) of RABV was
confirmed to play an important role in cytotoxicity and
induction of virus-neutralizing antibodies (VNA) [13, 29].
Another study indicated that RABV G may not be crucial
in pathogenicity and the expression of other viral proteins
was at a higher level while the expression of G was reduced
[30]. As shown in Figs. 4a and 5, the transcription and
translation of rHEP-NP-GFP G gene is significantly higher
than HEP-Flury and rHEP-GFP (at an early stage). This
may be one cause for decreased rHEP-GFP N expression.
The enhanced G protein expression of rHEP-NP-GFP may
lead to more VNA in vivo [19], which could protect host
from street strain of RABV. In addition, rHEP-NP-GFP
showed an increased transcription of viral N, P, and M at 1
Fig. 5 Western blot analysis of GFP, N, M, and G proteins
expression in NA cells infected with RABVs. NA cells were infected
with HEP-Flury, rHEP-GFP, or rHEP-NP-GFP at an MOI of 0.1, and
at day 1 or day 3, total proteins of cells were harvested to investigate
the GFP, N, M, and G protein expression using anti-GFP antibodies,
anti-RABV N antibodies, anti-RABV M antibodies, or anti-RABV G
antibodies, respectively. Gray analysis was conducted using Image J
and the data for measuring the expression of target proteins was
analyzed using GraphPad Prism 5
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dpi compared to the parent strain HEP-Flury. This may be
due to the increased activity of transcription caused by the
insertion of CT dinucleotide between N and GFP. How-
ever, the RNA synthesis of RABV is regulated by viral
proteins, which could not be produced without limit [6].
The decreased transcription of rHEP-NP-GFP at 3 dpi may
correlate with the negative regulation of viral proteins.
In the study, ISG20 was expressed at a higher level in
HEP-Flury at 1 dpi compared to rRABVs. ISG20 is a
product stimulated by IFN and has been demonstrated to
inhibit viral transcription and replication [31]. This may be
another reason for the lower viral proteins expression and
replication rates of HEP-Flury compared to rRABVs. In
previous researches, RABV P was demonstrated to be an
IFN antagonist that may decrease IFN gene expression and
interferon-induced STAT signaling [32, 33]. Our study
indicates that expressions of IFNa1 and STAT1 were
higher in NA cells that have been infected with HEP-Flury
compared to rHEP-GFP and rHEP-NP-GFP. This may be
related to the higher expression of rHEP-GFP and rHEP-
NP-GFP P.
It has been shown that N, P, and L were related to virus
RNA replication and transcription [34, 35], while M plays
an important role in virus assembling and budding [8]. This
indicates that changes of the structural protein of RABV
may affect the synthesis of RNA and virus replication. In
this study, HEP-Flury has a stronger ability to express N
and M compared to rHEP-NP-GFP (in the late stage). This
may be the reason that leads to an earlier maximum in virus
titer compared to rHEP-NP-GFP in NA cells.
In summary, to improve the expression of exogenous
genes, CT dinucleotide was introduced as the intergenic
region of N and GFP. This study shows that the rHEP-NP-
GFP (carrying GFP gene between N and P) significantly
affects the viral gene expression in vitro compared to
parent HEP-Flury and rHEP-GFP. Viral growth was not
affected by inserting GFP between N and P. Exogenous
gene expression was higher between N and P than between
G and L. This study indicates enhanced suitability of the
N/P site for the expression of exogenous genes compared
to the G/L. Moreover, it provides a foundation for gene
research of the rabies virus.
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